Article

The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary…

Disease Markers · 2019 · Xueyu Chen, author Binchun Lin, author Xiaoyun Xiong, author Panpan Sun, author Yanqing Kong, author Chuanzhong Yang, author Massimiliano M. Corsi Romanelli, Academic Editor

Key facts

Title The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants
First author Xueyu Chen, author Binchun Lin, author Xiaoyun Xiong, author Panpan Sun, author Yanqing Kong, author Chuanzhong Yang, author Massimiliano M. Corsi Romanelli, Academic Editor
Journal Disease Markers
Published Jul 11, 2019
DOI 10.1155/2019/5681954
Devices mentioned K000331, K000410, K000494, K000606, K001458, K003196, K003488, K010597, K010748, K011465, K013076, K013978 and 61 more
Product codes mentioned CDQ, CDT, CEK, CEO, CFJ, CFR, CGA, CGS, CGX, CHH, CHI, CIG and 73 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature